- 4
- 0
- 约2.16千字
- 约 43页
- 2020-03-15 发布于福建
- 举报
血液及其相关制剂在特护病房、重病房的应用;大纲说明; ; ; ;Thrombin;Severe Sepsis: New Concepts in Pathogenesis and Management; ;Drotrecogin Alfa (Activated); ;35;Mortality and APACHE II Quartile;Mortality and Numbers of Organs Failing;Recombinant Human Activated Protein C (rhAPC); ; ; ; ;“Who ?"Patient selection for rhAPC; ; ; ;Heparin Effect in Drotrecogin alfa (activated) Treatment; ;Transfusion Strategy (PRBC) in the Critically Ill Patients;Blood Products AdministrationRed Blood Cells;Conditions in Septic Patients that May Require a Higher Hemoglobin;Documented coagulopathy
Bleeding
Planned invasive procedures
W
原创力文档

文档评论(0)